Novartis UK Revenue

Pharmaceutical Manufacturing • London, England, United Kingdom • 201-500 Employees

Novartis UK revenue & valuation

Annual revenue	$25,300,000
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$80,800,000
Total funding	No funding

Key Contacts at Novartis UK

Sunil Arkar Modali

Director, Global Health Medical Affairs - Leprosy Program

Tim Morris

Director Of Biostatistics

Dilraj Singh

Director, Regulatory Affairs, Global Drug Development, Cmc

Alice Bidault

Medical Signatory Director Secondment

Ayan Das Gupta

Senior Director Biostatistics

Jaber Mohamed

Corporate Communications Director

Ron Hillel

Associate Director Clinical Development

Annaë Liu

Haematology Medical Director

Adam Brown

Medical Director, International Medical Affairs

Anna Halliday

Health Technology Appraisal & Health Economics & Outcomes Research Director

Company overview

Headquarters	The WestWorks, White City Place, London, W12 7FQ, GB
Website	novartis.co.uk
NAICS	3254
Keywords	Research, Biosimilars, Neuroscience, Innovation, Ophthalmology, Dermatology, Oncology, Immunology, Respiratory, Generic Medicines, Hepatology, Inflammatory, Cell And Gene Therapy
Founded	1996
Employees	201-500
Socials

Novartis UK Email Formats

Novartis UK uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@novartis.com), used 83.6% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@novartis.com	83.6%
{first initial}.{last name}	j.doe@novartis.com	15.1%

About Novartis UK

At Novartis we are reimagining medicine. We reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. Novartis is a leading medicines company powered by data and digital. In the UK we are proud to be part of the country’s thriving life sciences ecosystem, bringing innovative medicines to thousands of UK patients who rely on them to treat serious diseases such as cancer, multiple sclerosis, severe asthma, eye conditions, and many more. We have been awarded the exclusive ‘Top Employers’ certification for exceptional employee offerings for six consecutive years. About 105,000 people of 140 nationalities work at Novartis around the world, with over 1,300 based in the UK. Our people make our business. They discover, develop and facilitate access to our medicines. We have created a working environment that enables our associates to truly invest in their careers by giving them the support and flexibility they need. We have a range of talent programmes, development schemes and wellbeing initiatives to ensure a healthy personal and work life balance. Welcome to our page. Please take a look at our Community Guidelines for details about how to use and interact with our LinkedIn page: https://tinyurl.com/yxvyuq3d

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Manager

Entry

Director

Employees by Department

Novartis UK has 139 employees across 12 departments.

Departments

Number of employees

Funding Data

Novartis UK has never raised funding before.

Frequently asked questions

Novartis UK is located in London, England, GB.

Novartis UK generates an estimated annual revenue of $25,238,725. This revenue figure reflects the company's market position and business performance in its industry.

Novartis UK has an estimated valuation of $80,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Novartis UK was founded in 1996, making it 30 years old. The company has established itself as a significant player in its industry over this time.

Novartis UK has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.